Leflunomid (Leflunomide), Federal Court of Justice (Bundesgerichtshof), 24 July 2012
and Bernd Kröger. A combination of two pharmaceutical ingredients, i.e. leflunomide and teriflunomide is to be considered obvious if the person skilled in the art uses an obvious process to obtain leflunomide that automatically results in – even with a certain delay – both components due to a chemical reaction. Click here for the full text…